Código QR (código de barras bidimensional)

Tocilizumab combined with short-term high-dose glucocorticoids for rapid disease activity control and glucocorticoid reduction in adult-onset Still’s disease: a single-center retrospective study

ObjectivesThis study aimed to evaluate the effectiveness of tocilizumab (TCZ) combined with short-term high-dose glucocorticoids in rapidly controlling disease activity and reducing glucocorticoid use in patients with adult-onset Still’s disease (AOSD).MethodsIn this single-center retrospective stud...

ver descrição completa

Na minha lista:
Principais autores: Shi-Lei Zhong, Yan-Ping Lei, Li-Xuan Zhou, Ai-Xia Niu, Bo Liu, Yong-Long He, Qi-Bin Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-02-01
coleção:Frontiers in Immunology
Assuntos:
adult-onset still’s disease
biologic therapy
glucocorticoids
retrospective studies
tocilizumab
treatment outcome
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1732826/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados